Prediction of 19F NMR chemical shifts in labeled proteins: Computational protocol and case study

William C. Isley, Andrew K. Urick, William C Pomerantz, Chris Cramer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The structural analysis of ligand complexation in biomolecular systems is important in the design of new medicinal therapeutic agents; however, monitoring subtle structural changes in a protein's microenvironment is a challenging and complex problem. In this regard, the use of protein-based 19F NMR for screening low-molecular-weight molecules (i.e., fragments) can be an especially powerful tool to aid in drug design. Resonance assignment of the protein's 19F NMR spectrum is necessary for structural analysis. Here, a quantum chemical method has been developed as an initial approach to facilitate the assignment of a fluorinated protein's 19F NMR spectrum. The epigenetic "reader" domain of protein Brd4 was taken as a case study to assess the strengths and limitations of the method. The overall modeling protocol predicts chemical shifts for residues in rigid proteins with good accuracy; proper accounting for explicit solvation of fluorinated residues by water is critical.

Original languageEnglish (US)
Pages (from-to)2376-2386
Number of pages11
JournalMolecular Pharmaceutics
Volume13
Issue number7
DOIs
StatePublished - Jul 5 2016

Fingerprint

Proteins
Drug Design
Epigenomics
Molecular Weight
Ligands
Water
Therapeutics
Protein Domains

Keywords

  • DFT
  • F NMR
  • NMR
  • bromodomain
  • fluorine
  • screening

Cite this

Prediction of 19F NMR chemical shifts in labeled proteins : Computational protocol and case study. / Isley, William C.; Urick, Andrew K.; Pomerantz, William C; Cramer, Chris.

In: Molecular Pharmaceutics, Vol. 13, No. 7, 05.07.2016, p. 2376-2386.

Research output: Contribution to journalArticle

@article{bd71f735a4c04886849f2385c18f5f7d,
title = "Prediction of 19F NMR chemical shifts in labeled proteins: Computational protocol and case study",
abstract = "The structural analysis of ligand complexation in biomolecular systems is important in the design of new medicinal therapeutic agents; however, monitoring subtle structural changes in a protein's microenvironment is a challenging and complex problem. In this regard, the use of protein-based 19F NMR for screening low-molecular-weight molecules (i.e., fragments) can be an especially powerful tool to aid in drug design. Resonance assignment of the protein's 19F NMR spectrum is necessary for structural analysis. Here, a quantum chemical method has been developed as an initial approach to facilitate the assignment of a fluorinated protein's 19F NMR spectrum. The epigenetic {"}reader{"} domain of protein Brd4 was taken as a case study to assess the strengths and limitations of the method. The overall modeling protocol predicts chemical shifts for residues in rigid proteins with good accuracy; proper accounting for explicit solvation of fluorinated residues by water is critical.",
keywords = "DFT, F NMR, NMR, bromodomain, fluorine, screening",
author = "Isley, {William C.} and Urick, {Andrew K.} and Pomerantz, {William C} and Chris Cramer",
year = "2016",
month = "7",
day = "5",
doi = "10.1021/acs.molpharmaceut.6b00137",
language = "English (US)",
volume = "13",
pages = "2376--2386",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Prediction of 19F NMR chemical shifts in labeled proteins

T2 - Computational protocol and case study

AU - Isley, William C.

AU - Urick, Andrew K.

AU - Pomerantz, William C

AU - Cramer, Chris

PY - 2016/7/5

Y1 - 2016/7/5

N2 - The structural analysis of ligand complexation in biomolecular systems is important in the design of new medicinal therapeutic agents; however, monitoring subtle structural changes in a protein's microenvironment is a challenging and complex problem. In this regard, the use of protein-based 19F NMR for screening low-molecular-weight molecules (i.e., fragments) can be an especially powerful tool to aid in drug design. Resonance assignment of the protein's 19F NMR spectrum is necessary for structural analysis. Here, a quantum chemical method has been developed as an initial approach to facilitate the assignment of a fluorinated protein's 19F NMR spectrum. The epigenetic "reader" domain of protein Brd4 was taken as a case study to assess the strengths and limitations of the method. The overall modeling protocol predicts chemical shifts for residues in rigid proteins with good accuracy; proper accounting for explicit solvation of fluorinated residues by water is critical.

AB - The structural analysis of ligand complexation in biomolecular systems is important in the design of new medicinal therapeutic agents; however, monitoring subtle structural changes in a protein's microenvironment is a challenging and complex problem. In this regard, the use of protein-based 19F NMR for screening low-molecular-weight molecules (i.e., fragments) can be an especially powerful tool to aid in drug design. Resonance assignment of the protein's 19F NMR spectrum is necessary for structural analysis. Here, a quantum chemical method has been developed as an initial approach to facilitate the assignment of a fluorinated protein's 19F NMR spectrum. The epigenetic "reader" domain of protein Brd4 was taken as a case study to assess the strengths and limitations of the method. The overall modeling protocol predicts chemical shifts for residues in rigid proteins with good accuracy; proper accounting for explicit solvation of fluorinated residues by water is critical.

KW - DFT

KW - F NMR

KW - NMR

KW - bromodomain

KW - fluorine

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84979080320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979080320&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.6b00137

DO - 10.1021/acs.molpharmaceut.6b00137

M3 - Article

C2 - 27218275

AN - SCOPUS:84979080320

VL - 13

SP - 2376

EP - 2386

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 7

ER -